Inogen Announces the Appointment of Andy Reding as Chief Operating Officer
Inogen Appoints Andy Reding As COO, Effective On July 6, 2026
How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions
Inogen, Inc. Q1 2026 Earnings Call Summary
Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript
Inogen Q1 Earnings Call Highlights
Inogen (NASDAQ:INGN) Q1 2026 Earnings: Revenue Beat Masks Guidance Miss, Stock Dips
Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates
Inogen Announces First Quarter 2026 Financial Results
Inogen, Inc. 2026 Q1 - Results - Earnings Call Presentation
Inogen Affirms FY2026 Sales Guidance of $366.000M-$373.000M vs $369.267M Est
Inogen Sees Q2 Sales $94.000M-$97.000M vs $97.250M Est
Inogen Q1 Adj. EPS $(0.14) Beats $(0.28) Estimate, Sales $85.109M Beat $82.350M Estimate
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
We're Not Very Worried About Inogen's (NASDAQ:INGN) Cash Burn Rate
Inogen to Report First Quarter 2026 Financial Results on May 7, 2026
Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates
Inogen Unveils Growth Plan at Needham Conference: New CFO, Voxi 5, Simeox and Aurora Mask Push
Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.